영한_의학/질병_정미라

[한영과 19기 정미라]

영한_의학:질병_정미라.docx

24.43KB

영한_의학:질병_정미라.m4a

2.58MB

본 연설문은 Secretary Antony J. Blinken at the 67th Session of the UN Commission on Narcotic Drugs입니다.

Glossary

1	Secretary of State	국무부장관
2	UN Commission on Narcotic Drugs	유엔 마약위원회
3	Synthetic opioids	합성 오피오이드
4	methamphetamines	메타암페타민
5	ketamine	케타민
6	tramadol	트라마돌
7	Captagon	캡타곤
8	fentanyl	펜타닐
9	chemical precursors	화학적 전구물/원료물질

본문 (517단어, 5분 21초)

Well, good afternoon to everyone. Today marks the first time the United States Secretary of State has taken part in a session of the UN Commission on Narcotic Drugs. I’m here because, more than ever, fulfilling the mission of this institution is critical to the security, to the prosperity, to the health of the American people, just as it is to people of all of our nations.

Since this commission’s last high-level session three years ago, the number of Americans who have died of overdoses caused by synthetic opioids has nearly doubled – 74,000 people over that year. More than 40 percent of the American people know someone who has died from an opioid overdose. Synthetic drugs are now the number one killer of Americans aged 18 to 45.

Many of you are here for similar reasons. Now, the types of synthetic drug affecting your nations may vary. In some, it may be methamphetamines or ketamine; in others, tramadol, Captagon, fentanyl. The scale of the problem may be different. But in every region, use, dependence, overdose deaths by synthetic drugs are rising rapidly.

My message to this gathering is urgent. If we want to change the trajectory of this crisis, there is only one way to succeed, and that’s together. Now, for each one of us, for every nation, that has to start at home, including in the United States. Over the past three years, we’ve invested an unprecedented $169 billion to combat harmful drugs.

Under President Biden, the United States for the first time is dedicating more resources to tackling demand for drugs than to halting the supply. That means more resources for public awareness, for health interventions and services to prevent and reduce drug use, overdoses, and other harms, alongside measures to prevent, to detect, and stop the illicit manufacturing and trafficking of drugs.

This reflects the fundamental fact that untreated substance use and rising trafficking are two sides of the same coin. The more that we can help people break the cycle of use and dependence, the smaller the illicit market for drugs. The more we can reduce the illicit supply of harmful drugs, the fewer people will be exposed to them.

But while our efforts to the synthetic drug crisis start at home, they can’t end at home. This is, simply put, a problem that no one country can solve alone. The criminal groups that produce these drugs are agile. When one country cracks down on the production of a synthetic drug or the chemical precursors that go into making them, criminals quickly find another place to produce them. When one trafficking route is shut down, they shift to another.

They are constantly creating new drugs, too. Criminal organizations produce around 80 new synthetic drugs every year – many that are more potent than ones already circulating.  And they’re always looking for new markets and new users to boost their profits. So, if we want to successfully protect people in all of our countries, we simply can’t go it alone. I want to suggest four ways that we can work together to take effective action.